Corinne Jenkins Stock Analyst Profile - Goldman Sachs Research Coverage - Stocknear

Corinne Jenkins

Stock Analyst at Goldman Sachs

(4.2)
# 1805
Out of 5,506 analysts
78
Total ratings
Success rate
Average return

19 Stocks

Name Action PT Current % Upside Ratings Updated
RYTM Rhythm Pharmaceutica...
Maintains: Strong Buy
105 138
99.02 39.37% 9 Sep 24, 2025
ROIV Roivant Sciences
Maintains: Strong Buy
20 24
16.17 48.42% 6 Sep 18, 2025
GERN Geron
Reinstates: Sell
1
1.35 -25.93% 4 Jul 10, 2025
TGTX TG Therapeutics
Maintains: Neutral
20 22
36.7 -40.05% 8 Nov 5, 2024
ITCI Intra-Cellular Thera...
Maintains: Neutral
77 74
n/a n/a 5 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
6 15
9.22 62.69% 2 May 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
53 46
27.64 66.43% 5 May 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Neutral
13
3.91 232.48% 3 Jan 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
25 28
27.28 2.64% 7 Jan 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
47 52
n/a n/a 5 Nov 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
10 9
n/a n/a 5 Nov 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
332 296
n/a n/a 2 Nov 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
192 64
2.53 2429.64% 6 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
216 184
30.14 510.48% 2 Mar 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
25 21
1.86 1029.03% 2 Mar 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 14
8.23 70.11% 2 Dec 20, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
2
n/a n/a 1 Aug 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
9 8
n/a n/a 2 May 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
160
4.14 3764.73% 2 Dec 15, 2021